Dermatological signs in liver transplant recipients

Basit Öğe Kaydı
dc.authoridCenk, Hülya/0000-0003-4871-6342
dc.authoridBASKIRAN, ADIL/0000-0002-7536-1631
dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authorwosidCenk, Hülya/A-1293-2016
dc.authorwosidSARAÇ, Mehmet/AAE-4697-2020
dc.authorwosidBASKIRAN, ADIL/ABI-2356-2020
dc.authorwosidYilmaz, Sezai/ABI-2323-2020
dc.contributor.authorSarac, Gulbahar
dc.contributor.authorOzcan, Kubra Nur
dc.contributor.authorBaskiran, Adil
dc.contributor.authorCenk, Hulya
dc.contributor.authorSarac, Mehmet
dc.contributor.authorSener, Serpil
dc.contributor.authorYilmaz, Sezai
dc.date.accessioned2024-08-04T20:49:15Z
dc.date.available2024-08-04T20:49:15Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground In recent years, the number of liver transplantations for advanced-stage liver diseases has considerably increased and the patients have a wide range of dermatologic manifestations. Aim This study aims to reveal cutaneous, mucosal, and nail lesions in liver transplant recipients in quite large patient series. Patients/Methods The study included 520 patients in the Inonu University Liver Transplantation Institute. New and followed-up patients attended to the study between May and October 2019. The patients were examined by a dermatologist, and their data were recorded. Results The study included 163 female and 357 male patients with the main age of 44.20 +/- 18.18 (range: 1-83 years), and 465 livers (89.4%) were taken from live donors, while 54 livers (10.4%) were taken from cadavers. A total of 314 (60.4%) patients had dermatophyte infections, 174 (33.4%) patients had pathological nail changes, and 427 (82.1%) patients had oral mucosal lesions. Graft-versus-host disease (GVHD) developed in 9 (1.73%) patients after the transplantation, and 5 patients died of GVHD. Four patients had cutaneous malignancies. Conclusions Tumoral and nontumoral dermatological diseases may be encountered following the transplantation depending on underlying liver disease, immunosuppressive treatment, the graft itself, or any primary cutaneous disease. Liver transplantation recipients require a multidisciplinary clinical approach, and dermatological care must be an integral part of this approach.en_US
dc.identifier.doi10.1111/jocd.13944
dc.identifier.endpage2974en_US
dc.identifier.issn1473-2130
dc.identifier.issn1473-2165
dc.identifier.issue9en_US
dc.identifier.pmid33480152en_US
dc.identifier.scopus2-s2.0-85100003680en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage2969en_US
dc.identifier.urihttps://doi.org/10.1111/jocd.13944
dc.identifier.urihttps://hdl.handle.net/11616/99737
dc.identifier.volume20en_US
dc.identifier.wosWOS:000609287500001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal of Cosmetic Dermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectcutaneous findingsen_US
dc.subjectliveren_US
dc.subjectmucosal and nail findingsen_US
dc.subjectskin findingsen_US
dc.subjecttransplantationen_US
dc.titleDermatological signs in liver transplant recipientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu